Amazon and Warner Bros have put bid for a Radio Silence biopic about the late paranormal DJ Art Bell that would star Paul ...
BOSTON, Jan. 27, 2025 /PRNewswire/ -- Averna Therapeutics, Inc. ("Averna"; formerly known as Exsilio Therapeutics, Inc.), a biotechnology company developing genomic medicines that insert ...
Avengers director Joe Russo has been named on the board of Championship side Sheffield United, after the club was taken over by a U.S.-led consortium, COH Sports, last month. He was also named as ...
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that five posters across its ...
Apple CEO Tim Cook was in attendance at President Trump’s inauguration today in Washington, D.C., and has taken to social media to promise “continued innovation and jobs” for the United States.
Dr. Mohanty will discuss key challenges to modern gene therapy programs for rare disease indications. These will include the general lack of suitable animal models, established clinical endpoints, and ...
Thanks for joining us at Al Jazeera Sport. Brighton beat Manchester United in Matchweek 22 of the English Premier League season. Goals from Yankuba Minteh, Karou Mitoma and Giorginio Rutter sealed ...
After Amad Diallo's midweek hattrick for Manchester United, Ruben Amorim will hope Sunday's meeting with Brighton is a little less eventful than trailing Southampton until the 82nd minute.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.
These companies valuations have fluctuated since - Exelixis' is now valued at $10.65bn, Genmab, $13.7bn, Alnylam, $32.4bn, BioMarin, $11.7bn, and United Therapeutics, $16.1bn, while Sarepta's ...